Thanks. I'd just like to get a status update on it. It wasn't mentioned in the interview today.
I'm familiar with Breakthrough Designations, have been in a few pharmas that have gone through the process, and I think we'll need to get a good bit more data before we realistically have a chance of getting it. Applying after we get the data from the 25-30 patients Wayne expects to have by the end of the year seems to me like the obvious thing to do and I'm very interested in finding out Wayne's thoughts on it.
AGM questions to be submitted to the CEO, page-41
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.00 |
Change
0.150(1.01%) |
Mkt cap ! $317.0M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.15 | $14.30 | $210.2K | 14.26K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $14.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.00 | 5153 | 3 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |